Related Experiment Video

Updated: Aug 18, 2026

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice
07:35

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on: January 26, 2024

Acute hyperglycemia does not affect the reactivity of coronary microcirculation in humans

Brunella Capaldo1, Maurizio Galderisi, Anna Amelia Turco

  • 1Department of Clinical and Experimental Medicine, University Federico II, Naples, Italy. bcapaldo@unina.it

The Journal of Clinical Endocrinology and Metabolism
|March 31, 2005
PubMed

Insights

Short-term hyperglycemia does not impair coronary vasodilatory function in healthy individuals. This study found no significant effect of acute high blood sugar on coronary flow reserve, suggesting microcirculation remains unaffected.

Area of Science:

  • Cardiology
  • Endocrinology
  • Vascular Physiology

Background:

  • Acute hyperglycemia is suspected to induce vascular dysfunction.
  • Limited data exists on its impact on coronary vasodilatory function in healthy individuals.

Purpose of the Study:

  • To investigate the effect of acute, short-term hyperglycemia on coronary vasodilatory function in healthy subjects.

Main Methods:

  • Transthoracic color Doppler echocardiography measured left anterior descending coronary artery diastolic peak flow velocity in 13 healthy men.
  • Coronary flow reserve (CFR) was assessed in euglycemia and after 3 hours of hyperglycemia (approx. 14 mmol/L).
  • Hyperglycemia was induced using glucose and octreotide infusion to maintain stable insulin levels.

Main Results:

  • Resting diastolic flow velocity increased during hyperglycemia (P < 0.005).
  • Dipyridamole-induced increases in coronary flow velocity were similar in euglycemic and hyperglycemic states.
  • Coronary flow reserve (CFR) showed no significant difference between euglycemia and hyperglycemia (P = not significant).

Conclusions:

  • Short-term hyperglycemia does not significantly affect the vasodilatory response of the coronary microcirculation in healthy individuals.
  • These findings suggest that acute high blood sugar levels do not impair coronary blood flow regulation in this population.
Abstract

More Related Videos

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice11:10

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia09:35

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia

Published on: November 15, 2024

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...